Scientific Programme, ePosters & Abstracts
Rome, Italy 15 Sept 2022 - 17 Sept 2022
hrp0095fc2.1 | Bone, Growth Plate and Mineral Metabolism
hrp0095fc2.2 | Bone, Growth Plate and Mineral Metabolism
hrp0095fc2.3 | Bone, Growth Plate and Mineral Metabolism
hrp0095fc2.4 | Bone, Growth Plate and Mineral Metabolism
Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab vs conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period
hrp0095fc2.5 | Bone, Growth Plate and Mineral Metabolism
hrp0095fc2.6 | Bone, Growth Plate and Mineral Metabolism